Andere Sprachen Q-linea AB

Aktien

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:29:41 26.04.2024			% 5 Tage	% 1. Jan.
3.295 ^SEK	+64.91%		+59.56%	-10.95%

13.03.	Q-linea AB (publ) präsentiert starke ASTar-Ergebnisse auf der AMCLI	CI
27.02.	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea receives US FDA 510(k) clearance for the ASTar® System	26.04.
Q-linea publish the Annual report for 2023	12.04.
Q linea : Strong ASTar results presented at AMCLI	13.03.
Q-linea AB Presents Strong ASTar Results At AMCLI	13.03.
Q-linea participates in tender for rapid AST	05.03.
Year-end report 1 January – 31 December 2023	27.02.
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	27.02.
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27.02.
Q-linea presents at AMCLI	15.02.
Q-linea Presents at AMCLI	15.02.
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	09.02.
Q-linea creates separate subsidiary for Podler	09.02.
Q-linea signs agreement with logistics partner for the American market	08.02.
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024	01.02.
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	01.02.
Q-linea Lands First ASTar Order from Finnish Distributor	31.01.
Labema Oy places its first ASTar order	31.01.
Q-Linea AB Receives an Order for an ASTar System	31.01.
Q-linea to Cut 40 Jobs in Cost Savings Program	30.01.
Q-linea initiates cost savings program	30.01.

Keine Ergebnisse zu dieser Suche